Last checked at 14 Aug 2017 07:00
14 August 2017
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Notice of Results
Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that it will be reporting its interim results for the six months ended 30 June 2017 on Thursday 28 September 2017.
Enquiries: | |
Microsaic Systems plc Glenn Tracey, COO Bevan Metcalf, FD | +44 (0) 1483 751577 |
N+1 Singer (Nominated Adviser & Broker) Shaun Dobson Liz Yong James Hopton
| +44 (0)20 7496 3000 |
Citigate Dewe Rogerson (Financial PR) Mark Swallow Shabnam Bashir
| +44 (0)20 7638 9571 |
About Microsaic Systems
Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.
Microsaic's core product, the 4000 MiD®, is one of the smallest MS systems in the world, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.